AI business Tempus AI ( NASDAQ: TEM) reported third-quarter monetary outcomes Tuesday after market close.
Here are the essential highlights.
Q3 Outcomes: Tempus AI reported third-quarter profits of $334.21 million, up 84.7% year-over-year. The profits beat a Street agreement quote of $328.73 million according to information from Benzinga Pro.
Earnings from Genomics was $252.9 million in the quarter, up 117.2% year-over-year. Earnings from information and services was $81.3 million in the quarter, up 26.1% year-over-year.
The business reported an adjusted loss of 11 cents per share, beating a Street agreement quote of a loss of 17 cents per share.
Tempus AI reported 217,000 scientific tests provided in the 3rd quarter, up 33% year-over-year. Oncology volume development was up 27% year-over-year, with Genetic volume development up 37% year-over-year.
The business’s gross earnings was $209.9 million in the 3rd quarter, an enhancement of 98.4% from the previous year’s 3rd quarter. Changed EBITDA was $1.5 million in the 3rd quarter, compared to a loss of $21.8 million in in 2015’s 3rd quarter.
” Not just are we growing at an amazing rate, reaching favorable adjusted EBITDA marks a crucial turning point and shows the strength of our underlying company,” Tempus AI creator and CEO Eric Lefkofsky stated.
Tempus AI has actually ended up being a popular stock in 2025 with skyrocketing interest in expert system stocks. Rep. Nancy Pelosi (D-Calif.) divulged purchasing 50 call alternatives on Jan. 14, 2025. The alternatives have a strike rate of $20 and end on Jan. 16, 2026. ARK Funds, led by Cathie Wood, likewise owns shares of Tempus in the Ark Development ETF and Ark Genomic Transformation ETF, where the stock is a leading 10 holding in both.
What’s Next: The business raised its full-year 2025 profits assistance to $1.265 billion, up from a previous guide of $1.260 billion.
The business stated this profits assistance represents around 80% year-over-year development for the complete year.
Tempus AI’s acquisition of Paige is anticipated to increase losses by around $5 million per quarter, with the business assisting for fourth-quarter adjusted EBITDA to be around $20 million.
The business anticipates to have “a little favorable” changed EBITDA for the complete .
TEM Rate Action: Tempus AI stock is down 12.13% to $74.24 in after-hours trading Tuesday versus a 52-week trading series of $31.36 to $104.32.
Picture: T. Schneider by means of Shutterstock